Quantcast

Latest ICO Stories

2014-09-04 16:24:29

Based on Acclaimed PlayStation® Game CULVER CITY, Calif., Sept. 4, 2014 /PRNewswire/ -- Sony Pictures Entertainment today announced that Andres Muschietti has signed on to direct the highly-anticipated adaptation of best-selling PlayStation(®) software title, "Shadow of the Colossus." Seth Lochhead to write the screenplay (under Muschietti's supervision). Barbara Muschietti will come on board the project to produce alongside Kevin Misher, who produces through his Misher Films...

2014-08-29 08:24:15

VANCOUVER, Aug. 29, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) (OTCQX: ICOTF), today reported financial results for the six months ended June 30, 2014. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS"). Second Quarter 2014 Highlights -- Announced top-line results related to the eight month visual acuity (VA) primary endpoint for subjects enrolled in the...

2014-08-19 08:29:32

VANCOUVER, Aug. 19, 2014 /PRNewswire/ - iCo Therapeutics Inc. ("iCo" or "the Company") (TSX-V: ICO) (OTCQX: ICOTF), today reported results of its Oral Amphotericin B (Oral Amp B) drug candidate targeting latent HIV reservoirs. The study, conducted by ImmuneCarta®, the immune monitoring business unit of Caprion, evaluated in vitro effectiveness of Oral Amp B in reactivating latent HIV viral reservoirs which remain present in individuals despite intensive treatment with...

2014-06-30 08:29:48

VANCOUVER, June 30, 2014 /PRNewswire/ - iCo Therapeutics Inc. ("iCo" or "the Company") (TSX-V: ICO) (OTCQX: ICOTF) today announced that all nominees listed in the management information circular dated May 28, 2014 were elected as directors at its 2014 Annual Meeting of Shareholders, held on Friday, June 27, 2014. On a vote by ballot, the following five nominees proposed by management were elected as Directors of iCo Therapeutics to serve until the Company's next Annual Meeting of...

2014-06-09 08:29:08

VANCOUVER, June 9, 2014 /PRNewswire/ - iCo Therapeutics Inc. ("iCo" or "the Company") (TSX-V: ICO) (OTCQX: ICOTF) today announced top-line results related to the eight month visual acuity (VA) primary endpoint for subjects enrolled in the Phase 2 iDEAL Study, conducted in collaboration with JDRF, evaluating the efficacy and safety after repeated injections of iCo-007 in patients with Diabetic Macular Edema (DME). Statistical methods employed included both Last Observation Carry...

2014-05-29 16:27:05

VANCOUVER, May 29, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) (OTCQX: ICOTF), today reported financial results for the quarter ended March 31, 2014. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS"). "Excellent progress was made in the first quarter with the final eight month patient visit in our iDEAL study," said Andrew Rae, President & CEO of iCo...

2014-05-01 23:05:57

The pack contains all possible formats and comes with an application that works with Eclipse and Photoshop. It's distributed under CC Attribution-NoDerivs license. New York, NY (PRWEB) May 01, 2014 Icons8 is known for its largest icon packs for Windows 8 and iOS 7, together with 3940 icons. Now the company is adding Android icons too, starting with 500 icons. “We are sorry for ignoring the Android communities' needs for so long” - says Ivan Boyko, founder of Icons8. “So,...

2014-04-24 16:29:47

VANCOUVER, April 24, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) (OTCQX: ICOTF), today reported financial results for the year ended December 31, 2013. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS"). "Our team, working with world-class retinal experts, was extremely pleased with 2013 clinical progress," said Andrew Rae, President & CEO of iCo...

2014-03-05 08:28:36

VANCOUVER, March 5, 2014 /PRNewswire/ - iCo Therapeutics Inc. ("iCo" or "the Company") (TSX-V: ICO) (OTCQX: ICOTF) has announced the final month eight patient visit in the iDEAL Study. This US Phase 2 investigator-sponsored study is evaluating the efficacy and safety of iCo-007 after repeated injections in patients with Diabetic Macular Edema (DME). The study's primary endpoint is change in visual acuity from baseline to month eight, followed by secondary endpoints at month...

2014-02-25 12:28:26

VANCOUVER, Feb. 25, 2014 /PRNewswire/ - iCo Therapeutics Inc. ("iCo" or "the Company") (TSX-V: ICO) (OTCQX: ICOTF) today announced that its United States trading symbol ICOTF has received approval from The Depository Trust Company (the "DTC"), thus providing the Company with DTC eligibility. DTC eligibility allows for iCo Therapeutics shares to be easily and economically transferred between brokerage accounts electronically. The DTC is the largest securities depository in the...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related